Methimazole-induced bone marrow aplasia and liver damage;Aplazja szpiku i uszkodzenie watroby wywolane metimazolem

Polskie Archiwum Medycyny Wewnetrznej

Volumn 99, Issue 6, 1998, Pages 493-496

  Undas, Anetta ^a   Dreger, Beata ^a   Skałuba, Zofia ^a   Musiał, Jacek ^a  

^a II Kat Chorob Wewnetrznych C ^*

Author keywords

Agranulocytosis; Granulocyte colony stimulating factor (G CSF); Liver damage; Methimazole

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; THIAMAZOLE;

ADULT; AGRANULOCYTOSIS; ARTICLE; BONE MARROW APLASIA; CASE REPORT; FEMALE; HUMAN; LIVER INJURY; SKIN LUPUS ERYTHEMATOSUS;

EID: 0031757903     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. International Agraculocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. Br. Med. J. 1988, 297, 262.
2. Taijiri J., Noguchi S., Murakami T., Murakami N.: Anti-thyroid drug - induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch. Intern. Med., 1990, 150.
3. Cooper D.S.: Antithyroid drugs. N. Engl. J. Med., 1984, 331, 1353.
4. Meyer:Gessner M., Benker G., Olbricht T i wsp.: Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients. Dtsch. Med. Wochenschr., 1989, 114, 166.
5. Cooper D.S., Goldminz D., Levin A.A. i wsp.: Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann. Intern. Med., 1983, 98, 26.
6. Wall J.R., Fang S.L., Kuroki T., Ingbar S.H., Braverman L.E.: In vitro immunoreactivity to propylopthiouracyl, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J. Clin. Endocrinol. Metab., 1984, 58, 868.
7. Douer D., Eisenstein Z.: Methimazole-induced agranulocytosis: growth inhibitor of myeloid progenitor cells by the patients's serum Eur. J. Haematol., 1988, 40, 91.
8. Tamai H., Sudo T., Kimura A. i wsp.: Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann. Intern. Med., 1996, 124, 490.
9. Biswas N., Ahn Y.H., Goldman J.M., Schwartz J.M.. Aplastic anemia associated with antithyroid drugs. Am. J. Med. Sci., 1991, 301, 190.
10. Vitug A.C., Goldman J.M.: Hepatotoxicity from antithyroid drugs. Horm. Res., 1985, 21, 229.
11. Taijri J., Nogucho S., Okamura S. i wsp.: Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch. Intern. Med., 1993, 153, 509.
12. Kotlarek-Haus S., Podolak-Dawidziak M., Wróbei T.: Leczenie ostrej agranulocytozy polekowej czynnikiem stymuluja̧cym kolonie granulocytowe (G-CSF). Pol. Arch. Med. Wewn., 1994, 91, 127.